Summary:
- Researchers have developed a prenatal genetic therapy that shows promise in treating spinal muscle atrophy (SMA) in mice experiments.
- SMA is a rare and debilitating genetic disorder that affects the motor neurons, leading to progressive muscle weakness and loss of movement.
- The prenatal therapy involves delivering a healthy gene to the fetus, which helps produce a key protein that is lacking in SMA patients, potentially preventing the development of the disease.